UBS Group’s Surrozen Inc Warrant SRZNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,234
Closed -$55 – 11613
2026
Q2
$55 Buy
3,234
+533
+20% +$10 ﹤0.01% 10179
2026
Q1
$43 Buy
2,701
+1,101
+69% +$22 ﹤0.01% 10220
2025
Q4
$32 Buy
1,600
+211
+15% +$3 ﹤0.01% 10311
2025
Q3
$18 Sell
1,389
-51
-4% -$1 ﹤0.01% 10146
2025
Q2
$26 Sell
1,440
-1,314
-48% -$29 ﹤0.01% 10102
2025
Q1
$83 Buy
+2,754
New +$94 ﹤0.01% 9963
2024
Q2
– Sell
-3
Closed – – 10061
2024
Q1
$0 Sell
3
-9,097
-100% -$310 ﹤0.01% 9985
2023
Q4
$173 Buy
+9,100
New +$186 ﹤0.01% 8846
2023
Q1
– Sell
-509
Closed -$36 – 10329
2022
Q4
$36 Buy
+509
New +$76 ﹤0.01% 10510
2021
Q3
– Sell
-8
Closed – – 10057
2021
Q2
$0 Buy
+8
New +$9 ﹤0.01% 9794

UBS Group's SRZNW Position: Q3 2026 in Review

UBS Group sold out of Surrozen Inc Warrant (SRZNW) in Q3 2026, closing a stake of 3,234 shares — an estimated $55 sold.

UBS Group first reported a position in SRZNW in Q2 2021 and held it in 10 quarters. The position peaked at $173 in Q4 2023. 0 funds tracked by Wall St. Rank hold SRZNW as of Q3 2026.

  • UBS Group reported no remaining Surrozen Inc Warrant position as of Q3 2026 after selling out during the quarter.
  • UBS Group sold 3,234 Surrozen Inc Warrant shares in Q3 2026, an estimated $55.
  • UBS Group first reported a position in Surrozen Inc Warrant in Q2 2021 and held it in 10 quarters.
  • UBS Group's Surrozen Inc Warrant position peaked at $173 in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Surrozen Inc Warrant as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.